Clinical Social Workers in Tryon, NC Accepting Medicare
3 Clinical Social Workers found. Showing 1 - 3
 Julie Elizabeth Snyder, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 330 Carolina Dr, Tryon, NC 28782 Phone: 828-859-6661 Fax: 828-859-9487 |
Ms. Donna M. Tatnall, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 100 Jervey Rd, Tryon, NC 28782 Phone: 828-859-0492 Fax: 828-859-0492 |
 Robert Reid Fuller, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 35 Warrior Mountain Rd, Tryon, NC 28782 Phone: 828-859-3113 Fax: 828-894-2229 |
News Archive
Anti-TNFs increase risk of shingles in patients with inflammatory rheumatic diseases
Patients with inflammatory rheumatic diseases (IRD) treated with anti-tumour necrosis factor medications (anti-TNFs) have a 75% greater risk of developing herpes zoster, or shingles, than patients treated with traditional disease modifying anti-rheumatic drugs (DMARDs), according to a meta-analysis presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism.
Drug to treat multiple sclerosis may also hold promise for treating cardiac hypertrophy
A drug already approved to treat multiple sclerosis may also hold promise for treating cardiac hypertrophy, or thickening of the cardiac muscle-a disorder that often leads to heart failure, researchers at the University of Illinois at Chicago College of Medicine report.
LSHTM professor receives Canada Gairdner Global Health Award
Sir Brian Greenwood, Manson Professor of Clinical Tropical Medicine at the London School of Hygiene & Tropical Medicine, has dedicated his career to saving children's lives by tackling malaria, meningitis and pneumonia - diseases which are dictated by the weather.
WHO urges to address the high price and limited production of antibody combination for COVID-19
The World Health Organization (WHO) welcomes the addition of another therapeutic to the world's arsenal against COVID-19, but urges producing companies and governments to address the high price and limited production of the Regeneron antibody combination and ensure safe and appropriate handling of the medicine.
Taro Pharmaceutical Industries' non-sedating barbiturate compound study granted FDA IND exemption
Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.
› Verified 9 days ago
Dentists
Counselors
Pharmacists
Clinical Social Workers
Occupational Therapists
Psychologists